NASDAQ:KROS

Keros Therapeutics Earning Date

USA |NASDAQ |USD

KROS Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 8, 2021 Sep 2021 $-0.72 $-0.67 $-0.60
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 8, 2021 Sep 2021 $0.00 $100.00K $0.00

Keros Therapeutics's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 2021.

KROS Earnings Date & History Chart

KROS Earnings & Revenue Forecast

KROS Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $-0.81 $-1.01 $-0.65
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $-2.89 $-3.18 $-2.64
Dec 2022 3 $-4.03 $-4.85 $-3.61

KROS Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.81 $-0.81 $-0.78
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-2.89 $-2.89 $-2.84
Dec 2022 0 / 0 $-4.03 $-4.03 $-3.84

KROS Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 4 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $100.00K $100.00K $100.00K
Dec 2022 4 $0.00 $0.00 $0.00

KROS Earnings Date & Revenue History

KROS Earnings History

|
Show More
Show More

KROS Revenue History

|
Show More
Show More

Keros Therapeutics Next Earnings Date & Report

KROS Next Earnings Date & Report Preview: Sep 2021 (FQ)

KROS's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 4 analysts, the average EPS estimation for Keros Therapeutics's next quarterly earnings is $-0.72, with a low EPS estimation of $-0.81, and a high estimation of $-0.64.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.72, the last 2 month trend is $-0.72, and the 3 month trend is $-0.72.

Based on 4 analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.

Keros Therapeutics Previous Earnings Dates & Reports

KROS Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Keros Therapeutics's previous earnings date was Aug 5, 2021 for its fiscal quarter ended Jun 30, 2021.

KROS's earnings per share (EPS) was $-0.67, missing the consensus analysts forecast of $-0.66 by -2.29%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by -1.47%, and lower than the same period a year before (Jun 2020) by 8.06%.

Revenues were $100.00K.

The company reported a net income of $-15.62M.

Free cash flow for the quarter was $-18.15M , compared to $-10.71M last quarter and $-9.96M a year before.

KROS ended the quarter with $691.00K in total debt, a decrease of -13.30% compared to the previous quarter, and an increase of 72.75% compared to the same quarter a year before.

KROS Previous Earnings Date & Report Recap: Dec 2020 (FY)

Keros Therapeutics's previous annual earnings date was Mar 25, 2021 for its fiscal year ended Dec 31, 2020.

KROS's earnings per share (EPS) was $-6.82.

Revenues were $0.00.

The company reported a net income of $-45.36M.

Keros Therapeutics reported a free cash flow of $-37.19M for its fiscal year, compared to $-16.27M a year ago.

The company ended the fiscal year with $899.00K in total debt, a decrease of -29.49% compared to the previous year.